Contact us: +32 (0)7 848 2541

February Update: Health and Pharmaceuticals

30 January 2018

After opening with a Green Week, February promises to be a busy month in EU policymaking.

With the Bulgarian Presidency now in full swing, one of its key interests will be under discussion as the Commission publishes a strategy on the accession of Serbia and Montenegro to the EU.

Elsewhere, the Brexit negotiations look likely to continue making headlines as UK domestic tensions threaten the position of Prime Minister Theresa May.

Here, Anna Krouskou, DeHavilland EU's Policy Analyst for Health and Pharmaceuticals, gives you the lowdown on what to watch out for this February.

What's on the agenda this month

by Anna Krouskou, EU Policy Analyst

February will see the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency holding two meetings, from the 5th to the 7th and the 19th to the 22nd.
The Pharmacovigilance Risk Assessment Committee (PRAC) is also to meet from the 5th to the 8th, while the Committee for Orphan Medicinal Products (COMP) will convene from the 13th to the 15th.
Separately, MedTech Europe is to hold its 3rd Annual Healthcare Insurance Innovation Summit, on the 15th and the 16th, while the 4th European Conference on Clinical Research is to be hosted by the European Federation of Pharmaceutical Industries and Associations on the 26th and the 27th.
The Council Working Party on Public Health at Senior Level will also convene on the 12th, where the future of health, standardisation and medicines' affordability and availability will be discussed.

Get all the latest on the issues that matter from our dedicated EU Policy Analysts

DeHavilland EU's team of Policy Analysts offer you essential public affairs support to keep track of everything that matters.

Join us for a trial and you'll receive personalised support from Anna and the team, including alerts, live reports, roundups and acess to original research services.

Click here to request a free trial now.

Anna Krouskou, EU Policy Analyst
Anna Krouskou
EU Policy Analyst

Anna Krouskou is an EU Policy Analyst at DeHavilland EU. A graduate of the University of Athens and the London School of Economics and Political Science, she has previous experience working at Ketchum and the EU Council.